2010 June

Support for legalising cannabis has dropped from more than a third of people in Scotland to less than a quarter, a study has suggested.
However, most people made a distinction between cannabis and other drugs.
The findings come in a Scottish government study into the public’s attitudes towards illegal drugs and drug misuse.
It showed 47% of people knew someone who had tried illegal drugs, up from 41% between 2001 and 2009.
Statistics from the British Social Attitudes Surveys in the 1980s and 1990s, along with the Scottish Social Attitudes Survey 2001, indicated an increasingly tolerant attitude towards the legalisation of cannabis.
The results from the Scottish Social Attitudes Survey 2009 have now suggested a reverse in this trend.
Mental health
Support for legalising cannabis fell from 37% in Scotland in 2001 to 24% in 2009. Among those who had themselves tried cannabis, support for its legalisation fell from 70% to 47% over the same period.
The views were accompanied by a hardening of attitudes towards prosecution for the possession of cannabis.
The report found the trend may be linked to the mental health debate surrounding new stronger forms of cannabis, called skunk, or it may reflect a changing trend in attitudes towards illegal drugs in general.
In 2008 the government introduced a new strategy to tackle the nation’s drug problems by focusing on “recovery and helping people live drug-free lives”.
In principle this appeared to be supported by the Scottish public, with 80% saying “the only real way of helping drug addicts is to get them to stop using drugs altogether”.
How this should be done was not so clear, the report found.
There was widespread support for enforcement, with only 16% of people agreeing that personal use of heroin should not result in prosecution.
Although education was generally supported as the focus of drugs policy, only 44% of people believed this “education” should involve young people being given more information on how to use drugs more safely.
The survey also indicated that communities with higher signs of heroin use were more likely to be comfortable living near a recovering heroin user. This may mean that actual contact with such issues helps to allay public anxiety, it suggested.

Source: www.news.bbc.co.uk 25th May 2010

Filed under: Social Affairs :

Over the past ten days, 40 reports were received by the National Poisons Information Centre regarding persons suffering severe adverse reactions attributed to using a new head shop substance “WHACK”.
The majority of these individuals are young males in their twenties. They live in different parts of Ireland with 20 presenting in the mid-Western region. They have suffered a range of symptoms including increased heart and breathing rates and raised blood pressure. Emergency Physicians and GPs have described that the majority suffered from differing levels of anxiety with at least 7 cases experiencing psychotic episodes. This psychosis is severe and is proving difficult to treat.

The National Poisons Information Centre, the Forensic Science Laboratory, the Irish Medicines Board and others are monitoring closely the emergence of any new psychoactive substances.

On the 11th May 2010, the Government brought in new legislation. This legislation has brought under control approximately 200 individual substances and covers the vast majority of products of public health concern, which were on sale in head shops.

In addition to the recent controls on legal highs introduced by the Minister for Health and Children, the Minister for Justice and Law Reform is bringing forward the Criminal Justice (Psychoactive Substances) Bill 2010 which aims to ensure that the sale or supply of substances which may not be specifically proscribed under the Misuse of Drugs Act, but which have psychoactive effects, will be a criminal offence.

The advice from the HSE is not to try this dangerous drug or other similar substances as the effect on an individual can impact significantly on one’s health.

Source: HSE Press & Media, Dr Steevens’ Hospital, Dublin 8, 09/06/2010

Filed under: Drug Specifics :

Back to top of page

Powered by WordPress